跳至主要内容
临床试验/NCT01120678
NCT01120678已完成不适用

Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay

University of Virginia2 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2009年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
250
试验地点
2
主要终点
Cytokine response

研究概览

简要总结

The purpose of this study is to determine whether analysis of specific serum biomarkers will improve the diagnosis of late onset neonatal sepsis and to determine the correlation between plasma levels of specific cytokines and bacteremia in NICU patients >3 days of age.

详细描述

All infants in the Newborn Intensive Care Unit greater than three days old that had blood cultures sent were eligible for this study. Left-over blood from the time at blood culture was collected for research purposes. Study personnel separated the serum and stored samples at -80 degrees until analysis. Samples were analyzed in batch for neonatal sepsis biomarkers using an antibody-coated microsphere assay with dual laser detection. Clinical information collected included symptoms prompting the blood culture, CBC and culture results, and antibiotic therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
3 Days 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • NICU patients > 3 days of age

排除标准

  • less than 3 days old or no waste blood available

结局指标

主要结局

Cytokine response

时间窗: Within the first twenty-four hours after blood cultures are obtained.

次要结局

  • Heart rate characteristics(Within twenty-fours pre and post blood culture.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karen Fairchild, MD

Professor of Pediatrics

University of Virginia

研究点 (2)

Loading locations...

相似试验

Improved Detection of Neonatal Sepsis Using a... | 临床试验